{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:08:07Z","timestamp":1746245287014,"version":"3.40.4"},"reference-count":37,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"National Science and Technology Major Project","award":["2012ZX09303008-001"],"award-info":[{"award-number":["2012ZX09303008-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoepidemiol Drug Saf"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1002\/pds.3628","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T15:10:52Z","timestamp":1398179452000},"page":"1183-1191","source":"Crossref","is-referenced-by-count":7,"title":["The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris"],"prefix":"10.1002","volume":"23","author":[{"given":"Yan","family":"Li","sequence":"first","affiliation":[{"name":"Center of Clinical Pharmacology, Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases; Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linde","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Qinghai Province People's Hospital; Xining Qinghai Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishi","family":"Li","sequence":"additional","affiliation":[{"name":"Center of Clinical Pharmacology, Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases; Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfa","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Tongji Hospital Affiliated to Tongji University; Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Affiliated Hospital of Xuzhou Medical College; Xuzhou Jiangsu Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Second Affiliated Hospital of Xi'an Jiaotong University; Xi'an Shanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingtao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Fourth Hospital of Hebei Medical University; Shijiazhuang Hebei Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tongji Hospital, Tongji Medical College; Huazhong University of Science and Technology; Wuhan Hubei Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Renmin Hospital of Wuhan University; Wuhan Hubei Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianfa","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Affiliated Hospital of Hainan Medical College; Haikou Hainan Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaowen","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Shanghai First People's Hospital; Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Haikou People's Hospital; Haikou Hainan Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Wuxi People's Hospital; Wuxi Jiangsu Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinghua","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Second Hospital of Shandong University; Jinan Shandong Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongjian","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sichuan Provincial People's Hospital; Sichuan Academy of Medical Sciences; Chengdu Sichuan Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Gansu Provincial Hospital; Lanzhou Gansu Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiling","family":"Shou","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Shanxi Provincial People's Hospital; Xi'an Shanxi Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology; Hospital of Traditional Chinese Medicine of Xinjiang Uygur Autonomous Region; Urumchi Xinjiang Province China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youhong","family":"Jia","sequence":"additional","affiliation":[{"name":"Center of Clinical Pharmacology, Key Laboratory of Clinical Trial Research in Cardiovascular Drugs, Ministry of Health, State Key Laboratory of Cardiovascular Diseases; Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College; Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"10.1002\/pds.3628-BIB0001|pds3628-cit-0001","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Globlal Ans Regional Mortality From 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Diease Study 2010","volume":"380","author":"Lozaono","year":"2012","journal-title":"Lancet"},{"issue":"9524","key":"10.1002\/pds.3628-BIB0002|pds3628-cit-0002","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","article-title":"Global and Regional Burden of Disease and Risk Factors, 2001: Systematic Analysis of Population Health Data","volume":"367","author":"Lopez","year":"2006","journal-title":"Lancet"},{"issue":"14","key":"10.1002\/pds.3628-BIB0003|pds3628-cit-0003","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1056\/NEJM199604043341403","article-title":"Recent Trends in Acute Coronary Heart Disease-Mortality, Morbidity, Medical Care, and Risk Factors. The Minnesota Heart Survey Investigators","volume":"334","author":"McGobern","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/pds.3628-BIB0004|pds3628-cit-0004","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart Rate and Cardiovascular Mobility: The Framigham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"issue":"2","key":"10.1002\/pds.3628-BIB0005|pds3628-cit-0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003495-200666020-00001","article-title":"Impact of Increased Heart Rate On Clinical Outcomes in Hypertension: Implications for Antihypertensive Drug Therapy","volume":"66","author":"Palatini","year":"2006","journal-title":"Drugs"},{"issue":"5","key":"10.1002\/pds.3628-BIB0006|pds3628-cit-0006","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ehj.2003.12.003","article-title":"Increased Heart Rate and Reduced Heart-Rate Variability are Associated with Subclinical Inflammation in Middle-Aged and Elderly Subjects with No Apparent Heart Disease","volume":"25","author":"Sajadieh","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1002\/pds.3628-BIB0007|pds3628-cit-0007","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart Rate as a Prognostic Risk Factor in Patients with Coronay Atrtery Disease and Left-Ventricular Systolic Dysfunction (Beautiful): A Subgroup Analysis of a Randomised Controlled Trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"9744","key":"10.1002\/pds.3628-BIB0008|pds3628-cit-0008","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0140-6736(10)61259-7","article-title":"Heart Rate as a Risk Factor in Chronic Heart Failure (Shift): The Association Between Heart Rate and Outcomes in a Randomised Placebo-Controlled Trial","volume":"376","author":"Bohm","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/pds.3628-BIB0009|pds3628-cit-0009","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurjhf\/hfs104","article-title":"Resting Heart Rate and Incident Heart Failure in Apparently Healthy Men and Women in the Epic Norfork Study","volume":"14","author":"Pfister","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1002\/pds.3628-BIB0010|pds3628-cit-0010","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":"Heart Rate and Cardiac Rhym Relationships with Bisoprolol Benefit in Chronic Heart Falure in CibisiiTrial","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"issue":"6096","key":"10.1002\/pds.3628-BIB0011|pds3628-cit-0011","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/324470a0","article-title":"Characterization of Single Pacemaker Channels in Cardiac Sino-Atrial Node Cells","volume":"324","author":"DiFrancesco","year":"1986","journal-title":"Nature"},{"issue":"5719","key":"10.1002\/pds.3628-BIB0012|pds3628-cit-0012","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/280235a0","article-title":"How Does Adrenaline Accelerate the Heart?","volume":"280","author":"Brown","year":"1979","journal-title":"Nature"},{"issue":"23","key":"10.1002\/pds.3628-BIB0013|pds3628-cit-0013","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","article-title":"Efficacy of Ivabradine, a New Selective I(F) Inhibitor, Compared with Atenolol in Patients with Chronic Stable Angina","volume":"26","author":"Tardif","year":"2005","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1002\/pds.3628-BIB0014|pds3628-cit-0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2165\/00003495-200767030-00005","article-title":"Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris: A 3-Month Randomised, Double-Blind, Multicentre, Noninferiority Trial","volume":"67","author":"Ruzyllo","year":"2007","journal-title":"Drugs"},{"key":"10.1002\/pds.3628-BIB0015|pds3628-cit-0015","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","article-title":"Efficacy of the If Current Inhibitor Ivabradine in Patients with Chronic Stable Angina Receiving Beta Blocker Therapy a 4Month Randomized Placebo Controlled Trial","volume":"30","author":"Tardif","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1002\/pds.3628-BIB0016|pds3628-cit-0016","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1476-5381.1996.tb15505.x","article-title":"Mode of Action of Bradycardic Agent S16257 On Ionic Currents of Rabbit Sinoatrial Node Cells","volume":"118","author":"Bois","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1002\/pds.3628-BIB0017|pds3628-cit-0017","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0022-3565(24)29238-7","article-title":"Effects of Heart Rate Reduction with Ivabradine On Exercise-Induced Myocardial Ischemia and Stunning","volume":"299","author":"Monnet","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1002\/pds.3628-BIB0018|pds3628-cit-0018","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0300-8932(09)71041-3","article-title":"Ivabradine as a Treatment Option for Inappropriate Sinus Tachycardia","volume":"62","author":"Retegui","year":"2009","journal-title":"Rev Esp Cardiol"},{"issue":"2","key":"10.1002\/pds.3628-BIB0019|pds3628-cit-0019","doi-asserted-by":"crossref","first-page":"H676","DOI":"10.1152\/ajpheart.00564.2002","article-title":"Contributions of Heart Rate and Contractility to Myocardial Oxygen Balance During Exercise","volume":"284","author":"Colin","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1002\/pds.3628-BIB0020|pds3628-cit-0020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1124\/jpet.103.059717","article-title":"Effect of Graded Heart Rate Reduction with Ivabradine On Myocardial Oxygen Consumption and Diastolic Time in Exercising Dogs","volume":"308","author":"Colin","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/pds.3628-BIB0021|pds3628-cit-0021","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","article-title":"Antianginal and Antiischemic Effects of Ivabradine an If Inhibitor in Stable Angina a Randomized Double Blind Multicentered Placebocontrolled Trial","volume":"107","author":"Borer","year":"2003","journal-title":"Circulation"},{"key":"10.1002\/pds.3628-BIB0022|pds3628-cit-0022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000073933","article-title":"A Single Intravenous Dose of Ivabradine a Novel If Inhibitor Lowers Heart Rate but Doed Not Depress Left Ventticular Function in Patients with Left Ventricular Dysfunction","volume":"100","author":"Manz","year":"2003","journal-title":"Cardiology"},{"issue":"2","key":"10.1002\/pds.3628-BIB0023|pds3628-cit-0023","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2125.2005.02544.x","article-title":"Comparative Effects of Ivabradine, a Selective Heart Rate-Lowering Agent, and Propranolol On Systemic and Cardiac Haemodynamics at Rest and During Exercise","volume":"61","author":"Joannides","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1002\/pds.3628-BIB0024|pds3628-cit-0024","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines On the Management of Stable Angina Pectoris Executive Sumary the Task Force On the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1002\/pds.3628-BIB0025|pds3628-cit-0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000343631","article-title":"Ivabradine Improves All Aspects of Quality of Life Assessed with the 36 Item Short Form Health Survey in Subjects with Chronic Ischemic Heart Disease Compared with Bata Blockers","volume":"91","author":"Riccioni","year":"2013","journal-title":"Pharmacology"},{"key":"10.1002\/pds.3628-BIB0026|pds3628-cit-0026","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0009-9236(98)90153-9","article-title":"Pharmacokinetic Pharmacodynamic Modeling of the Effects of Ivabradine a Drect Sinus Node Inhibitor On Heart Rate in Healthy Volenteers","volume":"64","author":"Ragueneau","year":"1998","journal-title":"Clin Pharmacol Ther"},{"issue":"Pt 3","key":"10.1002\/pds.3628-BIB0027|pds3628-cit-0027","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1469-7793.1999.813ab.x","article-title":"Properties and Functional Roles of Hyperpolarization-Gated Currents in Guinea-Pig Retinal Rods","volume":"515","author":"Demontis","year":"1999","journal-title":"J Physiol"},{"key":"10.1002\/pds.3628-BIB0028|pds3628-cit-0028","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0028-3908(99)00207-5","article-title":"A Bradycardic Agent Zd7288 Blocks the Hyperpolarization Activated Current Ih in the Retinal Rod Phoreptors","volume":"39","author":"Satoh","year":"2000","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1002\/pds.3628-BIB0029|pds3628-cit-0029","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00126839-200304020-00001","article-title":"Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology","volume":"4","author":"Camm","year":"2003","journal-title":"Drugs R D"},{"issue":"9744","key":"10.1002\/pds.3628-BIB0030|pds3628-cit-0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and Outcomes in Chronic Heart Failure (SHIFT): A Randomised Placebo-Controlled Study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/pds.3628-BIB0031|pds3628-cit-0031","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00044011-200929050-00006","article-title":"Effect of Ivabradine, a Novel Antianginal Agent, On Driving Performance: A Randomized, Double-Blind, Placebo-Controlled Trial in Healthy Volunteers","volume":"29","author":"Macher","year":"2009","journal-title":"Clin Drug Investig"},{"issue":"13","key":"10.1002\/pds.3628-BIB0032|pds3628-cit-0032","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","article-title":"Long-Term Heart Rate Reduction Induced by the Selective I(F) Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure","volume":"109","author":"Mulder","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/pds.3628-BIB0033|pds3628-cit-0033","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/FJC.0b013e31823e5e01","article-title":"Heart Rate Reduction Induced by the If Current Inhibitor Ivabradine Improves Diastolic Function and Attenuates Cardiac Tissue Hypoxia","volume":"59","author":"Fang","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1002\/pds.3628-BIB0034|pds3628-cit-0034","doi-asserted-by":"crossref","first-page":"H322","DOI":"10.1152\/ajpheart.01337.2008","article-title":"Postmyocardial Infarction Remodeling and Coronary Reserve: Effects of Ivabradine and Beta Blockade Therapy","volume":"297","author":"Christensen","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1002\/pds.3628-BIB0035|pds3628-cit-0035","doi-asserted-by":"crossref","first-page":"H366","DOI":"10.1152\/ajpheart.01117.2009","article-title":"Heart Rate Reduction with Ivabradine Prevents the Global Phenotype of Left Ventricular Remodeling","volume":"300","author":"Ceconi","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9641","key":"10.1002\/pds.3628-BIB0036|pds3628-cit-0036","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for Patients with Stable Coronary Artery Disease and Left-Ventricular Systolic Dysfunction (BEAUTIFUL): A Randomised, Double-Blind, Placebo- Controlled Trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"issue":"14","key":"10.1002\/pds.3628-BIB0037|pds3628-cit-0037","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","article-title":"Esc Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3628","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpds.3628","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pds.3628\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:20:56Z","timestamp":1746195656000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.3628"}},"subtitle":["IVABRADINE VERSUS ATENOLOL IN CHINESE"],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"URL":"https:\/\/doi.org\/10.1002\/pds.3628","archive":["Portico"],"relation":{},"ISSN":["1053-8569"],"issn-type":[{"type":"print","value":"1053-8569"}],"subject":[],"published":{"date-parts":[[2014,4,22]]}}}